Sign On to a disability community letter to CMS Administrator, Dr. Mehmet Oz, regarding the recent unfortunate decision not to finalize the proposed expanded coverage for anti-obesity medications (“AOMs”) that was included in the CY 2026 Medicare Advantage and Medicare Part D Prescription Drug Benefit Programs proposed rule.
